Literature DB >> 9036936

HECA-452+ T cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium.

R Kunstfeld1, S Lechleitner, M Gröger, K Wolff, P Petzelbauer.   

Abstract

The skin is nourished by two interconnected vascular systems, the superficial vascular plexus coursing just beneath the epidermis and the deep vascular plexus located above the subcutaneous tissue. Skin inflammatory T cells in diseases, such as psoriasis or dermatitis, strikingly aim for the superficial vascular plexus without involving the deep vascular plexus, and the infiltrating T cells bear a distinct phenotype expressing the cutaneous lymphocyte-associated antigen, which is recognized by mAb HECA-452. We wanted to know whether HECA-452+ lymphocytes indeed are able to distinguish between superficial and deep vascular plexus homing sites. Employing the hu-SCID mouse model grafted with human skin and human T cells, as described previously, we developed a new skin-grafting strategy providing superficial and deep vascular plexus skin specimens placed separately onto the same mouse. Fourteen days after allogeneic human T cell grafting, both human skin sites were densely infiltrated by human T cells, but only T cells within the superficial vascular plexus, but not within the deep vascular plexus, expressed the cutaneous lymphocyte-associated antigen. IL-2 and IFN-gamma expression and allogeneic vessel destruction were present within both superficial and deep vascular plexus skin. This model provides direct evidence that expression of a specific homing receptor is indeed able to direct lymphocyte traffic, not only to a distinct organ but also to a distinct vascular bed within one organ.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036936     DOI: 10.1111/1523-1747.ep12286483

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Tuberculin-induced delayed-type hypersensitivity reaction in a model of hu-PBMC-SCID mice grafted with autologous skin.

Authors:  A Tsicopoulos; J Pestel; O Fahy; H Vorng; F Vandenbusche; H Porte; L Eraldi; A Wurtz; H Akoum; Q Hamid; B Wallaert; A B Tonnel
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 2.  Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation.

Authors:  Theresa Hautz; Dolores Wolfram; Johanna Grahammer; Ravi Starzl; Christoph Krapf; Johann Pratschke; W P Andrew Lee; Gerald Brandacher; Stefan Schneeberger
Journal:  Clin Dev Immunol       Date:  2012-09-19

3.  Pathological mechanisms of skin homing T cells in atopic dermatitis.

Authors:  Marta Ferran; Luis F Santamaria-Babi
Journal:  World Allergy Organ J       Date:  2010-03       Impact factor: 4.084

4.  Inhibitors of selectin functions in the treatment of inflammatory skin disorders.

Authors:  Michael P Schön
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

5.  Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway.

Authors:  S Lechleitner; J Gille; D R Johnson; P Petzelbauer
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.